A multifunctional persistent luminescent nanoprobe for imaging guided dual-stimulus responsive and triple-synergistic therapy of drug resistant tumor cells

Chem Commun (Camb). 2019 May 8;55(36):5283-5286. doi: 10.1039/c9cc01446b. Epub 2019 Apr 17.

Abstract

We report the design and fabrication of a multifunctional persistent luminescent nanoprobe for imaging guided dual-stimulus responsive and triple-synergistic therapy of drug resistant tumor. The integration of the dual-stimulus of an acidic microenvironment and laser irradiation with the triple-synergistic therapy of doxorubicin, photothermal and siRNA offers excellent therapeutic performance for drug resistant tumor cells with high specificity and little side effects.

MeSH terms

  • Antitubercular Agents / administration & dosage
  • Antitubercular Agents / adverse effects
  • Antitubercular Agents / therapeutic use*
  • Cell Line, Tumor
  • Combined Modality Therapy / methods*
  • Doxorubicin / administration & dosage
  • Doxorubicin / adverse effects
  • Doxorubicin / therapeutic use*
  • Drug Carriers / chemistry
  • Drug Liberation
  • Drug Resistance, Neoplasm
  • Drug Therapy / methods
  • Folic Acid / chemistry
  • Genetic Therapy / methods
  • Humans
  • Indoles / chemistry
  • Luminescent Agents / administration & dosage
  • Luminescent Agents / adverse effects
  • Luminescent Agents / therapeutic use*
  • Nanoparticles / chemistry
  • Optical Imaging / methods
  • Particle Size
  • Phototherapy / methods
  • Polyethyleneimine / chemistry
  • Polymers / chemistry
  • RNA, Small Interfering / administration & dosage
  • RNA, Small Interfering / adverse effects
  • RNA, Small Interfering / therapeutic use*
  • Surface Properties

Substances

  • Antitubercular Agents
  • Drug Carriers
  • Indoles
  • Luminescent Agents
  • Polymers
  • RNA, Small Interfering
  • polydopamine
  • Doxorubicin
  • Polyethyleneimine
  • Folic Acid